Minden MD - Search Results

1

Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature.

Tavor S, Shalit T, Chapal Ilani N, Moskovitz Y, Livnat N, Groner Y, Barr H, Minden MD, Plotnikov A, Deininger MW, Kaushansky N, Shlush LI. Tavor S, et al. Among authors: minden md. Haematologica. 2020 Dec 1;105(12):2795-2804. doi: 10.3324/haematol.2019.240705. Haematologica. 2020. PMID: 33256378 Free PMC article.

2

Expression of a retinoic acid receptor gene in myeloid leukemia cells.

Wang C, Curtis JE, Minden MD, McCulloch EA. Wang C, et al. Among authors: minden md. Leukemia. 1989 Apr;3(4):264-9. Leukemia. 1989. PMID: 2538684

3

Genetically determined regulators acting on the blast cells of acute myeloblastic leukemia.

McCulloch EA, Minden MD, Kelleher C, Miyauchi J, Wang C, Cheng GY. McCulloch EA, et al. Among authors: minden md. Acta Haematol. 1987;78 Suppl 1:18-25. doi: 10.1159/000205898. Acta Haematol. 1987. PMID: 2829486 Review.

4

Magnetic resonance imaging for monitoring relapse of acute myeloid leukemia.

Henkelman RM, Messner H, Poon PY, Hinks RS, Stewart C, Curtis J, Minden M, Baker M. Henkelman RM, et al. Leuk Res. 1988;12(10):811-6. doi: 10.1016/0145-2126(88)90034-3. Leuk Res. 1988. PMID: 3199840

5

Acute leukemia in adults.

Minden M, Imrie K, Keating A. Minden M, et al. Curr Opin Hematol. 1996 Jul;3(4):259-65. doi: 10.1097/00062752-199603040-00003. Curr Opin Hematol. 1996. PMID: 9372086 Review.

6

Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.

Brandwein JM, Gupta V, Schuh AC, Schimmer AD, Yee K, Xu W, Messner HA, Lipton JH, Minden MD. Brandwein JM, et al. Among authors: minden md. Am J Hematol. 2008 Jan;83(1):54-8. doi: 10.1002/ajh.21034. Am J Hematol. 2008. PMID: 17696207 Free article.

7

Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.

How J, Sykes J, Gupta V, Yee KW, Schimmer AD, Schuh AC, Minden MD, Kamel-Reid S, Brandwein JM. How J, et al. Among authors: minden md. Cancer. 2012 Dec 15;118(24):6110-7. doi: 10.1002/cncr.27683. Epub 2012 Jun 26. Cancer. 2012. PMID: 22736495 Free article.

8

FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients.

Han Y, Cui J, Lu Y, Sue S, Arpaia E, Mak TW, Minden MD. Han Y, et al. Among authors: minden md. Leuk Res. 2012 Nov;36(11):1339-46. doi: 10.1016/j.leukres.2012.06.011. Epub 2012 Aug 16. Leuk Res. 2012. PMID: 22902056

9

Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.

Sukhai MA, Prabha S, Hurren R, Rutledge AC, Lee AY, Sriskanthadevan S, Sun H, Wang X, Skrtic M, Seneviratne A, Cusimano M, Jhas B, Gronda M, MacLean N, Cho EE, Spagnuolo PA, Sharmeen S, Gebbia M, Urbanus M, Eppert K, Dissanayake D, Jonet A, Dassonville-Klimpt A, Li X, Datti A, Ohashi PS, Wrana J, Rogers I, Sonnet P, Ellis WY, Corey SJ, Eaves C, Minden MD, Wang JC, Dick JE, Nislow C, Giaever G, Schimmer AD. Sukhai MA, et al. Among authors: minden md. J Clin Invest. 2013 Jan;123(1):315-28. doi: 10.1172/JCI64180. Epub 2012 Dec 3. J Clin Invest. 2013. PMID: 23202731 Free PMC article. Clinical Trial.

10

Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia.

Fung FY, Li M, Breunis H, Timilshina N, Minden MD, Alibhai SM. Fung FY, et al. Among authors: minden md. Leuk Res. 2013 Mar;37(3):274-9. doi: 10.1016/j.leukres.2012.11.013. Epub 2012 Dec 20. Leuk Res. 2013. PMID: 23259987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters